Matches in SemOpenAlex for { <https://semopenalex.org/work/W2965349212> ?p ?o ?g. }
- W2965349212 endingPage "106331" @default.
- W2965349212 startingPage "106331" @default.
- W2965349212 abstract "ObjectiveThe objective of this study was to evaluate all-cause and epilepsy-specific healthcare resource utilization and costs following lacosamide (LCM) initiation as adjunctive therapy for the treatment of epilepsy.MethodsA noninterventional retrospective database analysis was conducted that examined patients diagnosed as having epilepsy who added LCM to existing antiepileptic drug (AED) therapy between 2009 and 2016 (the first LCM prescription was the index event). This study used a single-case design whereby patients served as their own controls. Patients were further required to have a minimum of 12 months of continuous eligibility before (preindex period) and after (postindex period) their index event. In the 12-month postindex period, the only allowed AED regimen change was the addition of LCM. Demographic and clinical characteristics were measured at index and during the preindex period, respectively. All-cause and epilepsy-specific healthcare resource utilization and costs were measured and compared in the pre- and postindex periods. Paired t- and McNemar's tests were conducted to assess the significant differences between pre- and postindex. Univariate analyses were used to analyze the impact of LCM on specific subpopulations.ResultsThe study sample comprised of 2171 patients: mean (standard deviation [SD]) age: 38.9 (19.3) years; 52.6% female. Just over half (56%) of these patients were on monotherapy before adding LCM. Prior to adding LCM, 28.8% of patients had an epilepsy-specific inpatient (IP) admission, and 35.7% of patients had an all-cause IP admission, compared with 18.2% and 26.1% of patients in the post-LCM period, respectively (both p < 0.0001). Likewise, 35.6% of patients had an epilepsy-specific emergency room (ER) visit, and 50.0% had an all-cause ER visit prior to adding LCM, compared with 23.8% and 42.1% in post-LCM, respectively (both p < 0.0001). After adding LCM, one-year mean [SD] epilepsy-specific IP admission costs decreased by 42.9% ($13,647 [$52,290] to $7788 [$32,321]), and all-cause IP admission costs decreased by 38.6% ($20,654 [$72,716] to $12,688 [$46,120]) (both p < 0.0001). One-year epilepsy-specific mean [SD] ER costs decreased by 35.2% ($691 [$1756] to $448 [$1909]; p < 0.0001), and all-cause ER cost decreased by 17.8% ($1217 [$3014] to $1000 [$2970]; p < 0.01).ConclusionsEpilepsy-related IP hospitalizations and ER visits (indicators of seizures) were significantly reduced in patients with epilepsy 12 months after adding LCM as an adjunctive therapy to existing AED treatment in a real-world setting, leading to reduced healthcare resource utilization and epilepsy costs." @default.
- W2965349212 created "2019-08-13" @default.
- W2965349212 creator A5018935336 @default.
- W2965349212 creator A5040175821 @default.
- W2965349212 creator A5074242701 @default.
- W2965349212 creator A5076295984 @default.
- W2965349212 creator A5090635124 @default.
- W2965349212 date "2019-10-01" @default.
- W2965349212 modified "2023-10-18" @default.
- W2965349212 title "Healthcare resource utilization and costs before and after lacosamide initiation as adjunctive therapy among patients with epilepsy in the United States" @default.
- W2965349212 cites W1482261919 @default.
- W2965349212 cites W1509746132 @default.
- W2965349212 cites W1866138264 @default.
- W2965349212 cites W1920696238 @default.
- W2965349212 cites W1970608368 @default.
- W2965349212 cites W1977688125 @default.
- W2965349212 cites W1984779237 @default.
- W2965349212 cites W1988264566 @default.
- W2965349212 cites W2004189054 @default.
- W2965349212 cites W2058959672 @default.
- W2965349212 cites W2084160703 @default.
- W2965349212 cites W2086132039 @default.
- W2965349212 cites W2100073316 @default.
- W2965349212 cites W2104308964 @default.
- W2965349212 cites W2135738480 @default.
- W2965349212 cites W2151075727 @default.
- W2965349212 cites W2154425407 @default.
- W2965349212 cites W2156203614 @default.
- W2965349212 cites W2165497088 @default.
- W2965349212 cites W2255313489 @default.
- W2965349212 cites W2331972294 @default.
- W2965349212 cites W2465855794 @default.
- W2965349212 cites W2588035751 @default.
- W2965349212 cites W2592509339 @default.
- W2965349212 cites W2620323758 @default.
- W2965349212 cites W2771493862 @default.
- W2965349212 cites W2793265380 @default.
- W2965349212 doi "https://doi.org/10.1016/j.yebeh.2019.05.027" @default.
- W2965349212 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31399339" @default.
- W2965349212 hasPublicationYear "2019" @default.
- W2965349212 type Work @default.
- W2965349212 sameAs 2965349212 @default.
- W2965349212 citedByCount "6" @default.
- W2965349212 countsByYear W29653492122022 @default.
- W2965349212 countsByYear W29653492122023 @default.
- W2965349212 crossrefType "journal-article" @default.
- W2965349212 hasAuthorship W2965349212A5018935336 @default.
- W2965349212 hasAuthorship W2965349212A5040175821 @default.
- W2965349212 hasAuthorship W2965349212A5074242701 @default.
- W2965349212 hasAuthorship W2965349212A5076295984 @default.
- W2965349212 hasAuthorship W2965349212A5090635124 @default.
- W2965349212 hasBestOaLocation W29653492121 @default.
- W2965349212 hasConcept C105795698 @default.
- W2965349212 hasConcept C118552586 @default.
- W2965349212 hasConcept C126322002 @default.
- W2965349212 hasConcept C160735492 @default.
- W2965349212 hasConcept C162324750 @default.
- W2965349212 hasConcept C167135981 @default.
- W2965349212 hasConcept C186282968 @default.
- W2965349212 hasConcept C187212893 @default.
- W2965349212 hasConcept C194828623 @default.
- W2965349212 hasConcept C2426938 @default.
- W2965349212 hasConcept C2778139780 @default.
- W2965349212 hasConcept C2778186239 @default.
- W2965349212 hasConcept C3018162438 @default.
- W2965349212 hasConcept C33923547 @default.
- W2965349212 hasConcept C50522688 @default.
- W2965349212 hasConcept C71924100 @default.
- W2965349212 hasConcept C98274493 @default.
- W2965349212 hasConceptScore W2965349212C105795698 @default.
- W2965349212 hasConceptScore W2965349212C118552586 @default.
- W2965349212 hasConceptScore W2965349212C126322002 @default.
- W2965349212 hasConceptScore W2965349212C160735492 @default.
- W2965349212 hasConceptScore W2965349212C162324750 @default.
- W2965349212 hasConceptScore W2965349212C167135981 @default.
- W2965349212 hasConceptScore W2965349212C186282968 @default.
- W2965349212 hasConceptScore W2965349212C187212893 @default.
- W2965349212 hasConceptScore W2965349212C194828623 @default.
- W2965349212 hasConceptScore W2965349212C2426938 @default.
- W2965349212 hasConceptScore W2965349212C2778139780 @default.
- W2965349212 hasConceptScore W2965349212C2778186239 @default.
- W2965349212 hasConceptScore W2965349212C3018162438 @default.
- W2965349212 hasConceptScore W2965349212C33923547 @default.
- W2965349212 hasConceptScore W2965349212C50522688 @default.
- W2965349212 hasConceptScore W2965349212C71924100 @default.
- W2965349212 hasConceptScore W2965349212C98274493 @default.
- W2965349212 hasFunder F4320337846 @default.
- W2965349212 hasLocation W29653492121 @default.
- W2965349212 hasLocation W29653492122 @default.
- W2965349212 hasOpenAccess W2965349212 @default.
- W2965349212 hasPrimaryLocation W29653492121 @default.
- W2965349212 hasRelatedWork W2255313489 @default.
- W2965349212 hasRelatedWork W2599353587 @default.
- W2965349212 hasRelatedWork W2778132151 @default.
- W2965349212 hasRelatedWork W2805536053 @default.
- W2965349212 hasRelatedWork W2965349212 @default.
- W2965349212 hasRelatedWork W3182709878 @default.
- W2965349212 hasRelatedWork W4205529031 @default.